Mindspeaker’s CEO Arno Libert on company progress

Archive note — updated 10 September 2026. This page originally presented an interview with Arno Libert, quoted as MindSpeaker’s CEO at the time. The original publication date is retained. The editorial summary below replaces outdated availability forecasts and overstatements of product capability; it is not a new quotation from the interviewee.

The development vision

The interview discussed the need for accessible communication tools and research into non-invasive wearable brain-computer interfaces. Adapting access methods to a person’s changing needs remains a development objective, not a guarantee of lifelong suitability or recovery of natural speech.

What MindClick is being developed to do

The current programme explores trained control signals that make selections in communication software. A user constructs a message from letters, words or symbols. MindClick does not read free-form thoughts or decode complete intended sentences directly from EEG. Voice cloning is a separate software function and is not restoration of natural speech through brain decoding.

Our staged approach evaluates a deliberate facial activation followed by trained movement-related EEG selections. It requires a usable residual facial signal and an individually established EEG pattern. Reliability and usability must be assessed for the relevant configuration and population.

Regulatory and availability correction

The earlier suggestion that a product can automatically be offered as non-medical while awaiting medical-device status was too broad. Intended purpose, promotional claims and actual supply arrangements determine the applicable requirements. “Research Use Only” is not a general exemption for routine patient use.

The correct classification term is “Class I”, not “type 1”. The classification of the actual offering must be justified. Ordinary Class I conformity generally involves the manufacturer’s declaration and CE marking rather than waiting for a regulator to grant a certificate. The earlier 2024–2025 availability forecasts should not be relied on.

Discuss a prototype demonstration or research partnership.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top